Pyrazole-related nucleosides. 4. Synthesis and antitumor activity of some 1-tetrahydropyranyl-4-substituted pyrazoles. 1996

S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Italy.

Continuing our studies on the structure-activity relationships of some pyrazole nucleosides (1a-h) structurally related to ribavirin, tiazofurin and selenazofurin, we describe here the synthesis and antitumor/antiviral/antimicrobial activity of a new series of 1-tetrahydropyranyl-4-substituted pyrazoles. In this study, the tetrahydropyranyl moiety (THP), designed as a mimic of the glycosidic portion of the parent compounds 1a-h, has led to a few derivatives with moderate cytotoxic activity against leukemia/lymphoma and solid tumor-derived cell lines (IC50 14-100 microM). The compounds obtained through substitution of the ribofuranosyl moiety by the THP moiety were still active, the free heterocyclic bases were devoid of any activity.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011714 Pyrans Pyran
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
September 1976, The Journal of organic chemistry,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
January 2001, Die Pharmazie,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
April 1974, Die Pharmazie,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
June 1981, Journal of medicinal chemistry,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
August 1975, Journal of medicinal chemistry,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
January 1989, Farmaco (Societa chimica italiana : 1989),
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
February 1987, Journal of medicinal chemistry,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
January 1976, Polish journal of pharmacology and pharmacy,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
May 1969, Journal of medicinal chemistry,
S Manfredini, and R Bazzanini, and P G Baraldi, and M Bonora, and M Marangoni, and D Simoni, and A Pani, and F Scintu, and E Pinna, and L Pisano, and P La Colla
June 2014, Archiv der Pharmazie,
Copied contents to your clipboard!